BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.09B |
| 2 |
Tesla
TSLA
|
+$488M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$271M |
| 5 |
Abbott
ABT
|
+$253M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$642M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Visa
V
|
+$487M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$441M |
| 5 |
Technology Select Sector SPDR Fund
XLK
|
+$252M |
Sector Composition
| 1 | Technology | 18.06% |
| 2 | Financials | 12.01% |
| 3 | Consumer Discretionary | 9.98% |
| 4 | Healthcare | 8.94% |
| 5 | Communication Services | 6.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LUNA
2901
DELISTED
Luna Innovations Incorporated
LUNA
| $14.1K | ﹤0.01% |
1,300
-2,657
| -67% | -$28.8K |
|
|
KIN
2902
DELISTED
Kindred Biosciences, Inc.
KIN
| $14.1K | ﹤0.01% |
1,535
-3,638
| -70% | -$33.4K |
|
|
LJPC
2903
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $13.9K | ﹤0.01% |
3,248
+476
| +17% | +$2.04K |
|
2904
CytomX Therapeutics
CTMX
$341M
| $13.9K | ﹤0.01% |
2,193
-14,736
| -87% | -$93.3K |
|
|
EXTN
2905
DELISTED
Exterran Corporation
EXTN
| $13.9K | ﹤0.01% |
2,912
-11,847
| -80% | -$56.4K |
|
2906
Oramed Pharmaceuticals
ORMP
$95.5M
| $13.8K | ﹤0.01% |
+1,029
| New | +$13.8K |
|
2907
Vanguard Value ETF
VTV
$144B
| $13.7K | ﹤0.01% |
+100
| New | +$13.7K |
|
|
ENZ
2908
DELISTED
Enzo Biochem, Inc.
ENZ
| $13.6K | ﹤0.01% |
4,282
-13,656
| -76% | -$43.3K |
|
|
CASA
2909
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $13.6K | ﹤0.01% |
1,528
-3,353
| -69% | -$29.7K |
|
2910
AgEagle Aerial Systems
UAVS
$69.8M
| $13.5K | ﹤0.01% |
+3
| New | +$13.5K |
|
2911
Allient
ALNT
$774M
| $13.5K | ﹤0.01% |
392
-1,372
| -78% | -$47.4K |
|
2912
Identive
INVE
$89.2M
| $13.5K | ﹤0.01% |
+796
| New | +$13.5K |
|
2913
Vitamin Cottage Natural Grocers
NGVC
$833M
| $13.5K | ﹤0.01% |
1,257
-1,058
| -46% | -$11.4K |
|
2914
InfuSystem Holdings
INFU
$206M
| $13.4K | ﹤0.01% |
646
-1,209
| -65% | -$25.1K |
|
2915
Ovid Therapeutics
OVID
$88.9M
| $13.4K | ﹤0.01% |
3,434
-2,440
| -42% | -$9.54K |
|
2916
LiveOne
LVO
$58.6M
| $13.3K | ﹤0.01% |
2,827
-17,017
| -86% | -$80.3K |
|
|
MFGP
2917
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $13.3K | ﹤0.01% |
1,769
| – | – |
|
2918
Spero Therapeutics
SPRO
$109M
| $13.2K | ﹤0.01% |
947
-13,382
| -93% | -$187K |
|
2919
Pure Cycle
PCYO
$266M
| $13.2K | ﹤0.01% |
956
-1,447
| -60% | -$20K |
|
2920
Meridian
MRBK
$176M
| $13.1K | ﹤0.01% |
998
-3,540
| -78% | -$46.5K |
|
|
RVLP
2921
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $13.1K | ﹤0.01% |
4,347
-526
| -11% | -$1.58K |
|
|
DS
2922
DELISTED
Drive Shack Inc.
DS
| $13.1K | ﹤0.01% |
3,950
+2,476
| +168% | +$8.2K |
|
2923
Televisa
TV
$1.48B
| $13.1K | ﹤0.01% |
914
-60,400
| -99% | -$863K |
|
2924
American Realty Investors
ARL
$263M
| $13K | ﹤0.01% |
1,393
-956
| -41% | -$8.9K |
|
2925
Limoneira
LMNR
$269M
| $12.9K | ﹤0.01% |
735
-4,469
| -86% | -$78.4K |
|